FRAZIER MANAGEMENT LLC - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$57,360,000
+59.4%
2,082,789
-4.6%
5.29%
+83.2%
Q1 2021$35,994,000
-10.5%
2,182,7890.0%2.89%
-6.8%
Q4 2020$40,229,000
+35.4%
2,182,7890.0%3.10%
+16.2%
Q3 2020$29,708,000
-24.1%
2,182,7890.0%2.67%
-22.4%
Q2 2020$39,116,000
+79.7%
2,182,7890.0%3.44%
+39.2%
Q1 2020$21,762,000
+22.5%
2,182,7890.0%2.47%
-17.2%
Q4 2019$17,768,000
-17.9%
2,182,7890.0%2.98%
-55.9%
Q3 2019$21,631,000
+1.8%
2,182,789
+29.7%
6.76%
+24.2%
Q2 2019$21,254,0001,682,7895.45%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders